Actively Recruiting
Registry to Collect Data on Boston Scientifics Vercise Deep Brain Stimulation System for Parkinsons Disease and Evaluate Programming Tools
Led by Boston Scientific Corporation · Updated on 2026-10-13
1500
Participants Needed
87
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are collecting worldwide data on the use of Boston Scientifics Vercise Deep Brain Stimulation DBS System for treating Parkinsons disease. This registry aims to understand how patients respond to the DBS treatment and how it affects their quality of life. The study also evaluates the use of Image Guided Programming IGP and the DBS Illumina 3D feature as tools to help plan patient programming with the Vercise DBS system. Participants receive the Vercise DBS device as part of their Parkinsons disease treatment. The study observes the use of various programming tools, including IGP and the Illumina 3D feature, that assist clinicians in adjusting the DBS device settings to optimize therapy. These programming techniques are monitored and assessed throughout the study. During the registry, participants symptoms and quality of life are tracked and compared to their baseline status before DBS treatment. Data collection includes monitoring symptom improvements and overall well-being up to three years after treatment. This long-term observation helps researchers understand the outcomes and benefits of using the Vercise DBS system for Parkinsons disease.
CONDITIONS
Brief Title
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Research Team
H
Heleen Scholtes
A
Alison Lewis
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here